| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Isocitrate dehydrogenase [NADP] cytoplasmic [R132C] |
|---|
| Ligand | BDBM363683 |
|---|
| Substrate/Competitor | n/a |
|---|
| IC50 | <100±n/a nM |
|---|
| Citation |  Lemieux, RM; Popovici-Muller, J; Travins, J; Cai, Z; Cui, D; Zhou, D Therapeutically active compounds and their methods of use US Patent US11021515 Publication Date 6/1/2021 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Isocitrate dehydrogenase [NADP] cytoplasmic [R132C] |
|---|
| Name: | Isocitrate dehydrogenase [NADP] cytoplasmic [R132C] |
|---|
| Synonyms: | IDH1 | IDH1 R132C | IDH1(R132C) | IDHC_HUMAN | Isocitrate dehydrogenase (IDH1)(R132C) | Isocitrate dehydrogenase 1 mutant (R132C) | Isocitrate dehydrogenase [NADP] cytoplasmic (IDH1) (R132C) | PICD |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 46607.23 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O75874[R132C] |
|---|
| Residue: | 414 |
|---|
| Sequence: | MSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDA
AEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRL
VSGWVKPIIIGCHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAM
GMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFE
AQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDG
KTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALE
EVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL
|
|
|
|---|
| BDBM363683 |
|---|
| n/a |
|---|
| Name | BDBM363683 |
|---|
| Synonyms: | US10640534, Compound 170 | US10689414, Compound 170 | US10717764, Compound 170 | US11021515, Compound 170 | US11667673, Compound 170 | US9850277, Compound 170 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C30H23ClF2N6O4 |
|---|
| Mol. Mass. | 604.991 |
|---|
| SMILES | O[C@@H]1C[C@H](N(C1=O)c1cc(ccn1)C#N)C(=O)N(C(C(=O)NC1CC(F)(F)C1)c1ccccc1Cl)c1cccc(c1)C#N |r| |
|---|
| Structure | 
|
|---|
Search and Browse
